Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to
assemble and peer-review its pathway modules. The integration of ORCID within Reactome
enables us to meet a key challenge with authoring, curating and reviewing biological
information by incentivizing and crediting the external experts that contribute their
expertise and time to the Reactome curation process. More information is available at
ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please
forward this information to us and we will update your Reactome pathway records.
Details on Person Goadsby, Peter J
| Class:Id | Person:9702362 |
|---|
| _displayName | Goadsby, Peter J |
|---|
| _timestamp | 2020-09-30 14:57:41 |
|---|
| created | [InstanceEdit:9702388] Jassal, Bijay, 2020-09-30 |
|---|
| firstname | Peter J |
|---|
| initial | PJ |
|---|
| surname | Goadsby |
|---|
| (author) | [LiteratureReference:9702344] Fremanezumab for the Preventive Treatment of Chronic Migraine
[LiteratureReference:9702370] Effect of Different Doses of Galcanezumab vs Placebo for Episodic Migraine Prevention: A Randomized Clinical Trial
[LiteratureReference:9702386] Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial
[LiteratureReference:9702782] One-year sustained efficacy of erenumab in episodic migraine: Results of the STRIVE study
[LiteratureReference:9702824] Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial
[LiteratureReference:9702868] Recent Advances in Pharmacotherapy for Episodic Migraine |
|---|
|
[Change default viewing format]
|
No pathways have been reviewed or authored by Goadsby, Peter J (9702362)
